Skip to main content
SpringerLink
Log in

Diabetes as a Systemic Factor for Peri-implantitis

  • Chapter
  • First Online:
Risk Factors for Peri-implant Diseases

  • 487 Accesses

Abstract

Diabetes has long been considered a relative contraindication to implant placement on the basis of glycemic control. This impact of diabetes on the success of implant therapy was thought based on concerns about wound healing and infection for patients with diabetes and less so on sound evidence. Our understanding of the assessments of glycemia and our scientific evidence regarding outcomes for dental implants become critical to the appropriate application of this therapy. Evaluating the evidence for both early (failure to integrate) and late (peri-implantitis) implant complications suggests that the effects of diabetes and hyperglycemia appear more modest than may be otherwise considered. It is clear that dental implant therapy offers important opportunities to improve oral health and quality of life. While our information to date does support some increase in risk for patients with diabetes, especially those with elevated glycemic levels, the added risk for marginal bone loss approaching 1 mm more than non-diabetic individuals over a 10-year period pales in comparison to the obvious benefits implant therapy can offer a dentally debilitated individual dependent on dietary management of their condition. As we continue to investigate dental implant therapy for individuals with diabetes and the associated risks for these individuals, we will need to gain considerable insights into the true benefits of this treatment approach within this population.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. ADA, American Diabetes Association. 2019.; http://www.diabetes.org/diabetes-basics/statistics/?loc=db-slabnav.

  2. Sato Y, Kitagawa N, Isobe A. Implant treatment in ultra-aged society. Jpn Dent Sci Rev. 2018;54(2):45–51.

    Article  PubMed  PubMed Central  Google Scholar 

  3. World Workshop in Periodontics. Proceedings of the 1996 World Workshop in Periodontics. Lansdowne, Virginia, July 13–17, 1996. Ann Periodontol. 1996;1(1):1–947.

    Article  Google Scholar 

  4. Dental Implants. NIH Consensus Statement Online 1988 Jun 13–15 [2109, 09, 01];7(3):1-22.

    Google Scholar 

  5. Oates TW, Huynh-Ba G, Vargas A, Alexander P, Feine J. A critical review of diabetes, glycemic control, and dental implant therapy. Clin Oral Implants Res. 2013;24(2):117–27.

    Article  PubMed  Google Scholar 

  6. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab. 2008;93(7):2447–53.

    Article  PubMed  Google Scholar 

  7. Nathan DM, Kuenen J, Borg R, Zheng H, Schoenfeld D, Heine RJ. Translating the A1c assay into estimated average glucose values. Diabetes Care. 2009;32(1):207.

    Article  Google Scholar 

  8. Trevino G. On the weighted-average relationship between plasma glucose and HbA1c. Diabetes Care. 2006;29:466.

    Article  PubMed  Google Scholar 

  9. Cornell S. Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE. J Am Pharm Assoc (2003). 2017;57(2):261–5.

    Article  Google Scholar 

  10. Diabetes Control and Complications Trial (DCCT) Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, Davis M, Rand L, Siebert C. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86.

    Article  Google Scholar 

  11. UKPDS. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53.

    Article  Google Scholar 

  12. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140–9.

    Article  PubMed  Google Scholar 

  13. Dowell S, Oates TW, Robinson M. Implant success in people with type 2 diabetes mellitus with varying glycemic control: a pilot study. J Am Dent Assoc. 2007;138(3):355–61.

    Article  PubMed  Google Scholar 

  14. Turkyilmaz I. One-year clinical outcome of dental implants placed in patients with type 2 diabetes mellitus: a case series. Implant Dent. 2010;19(4):323–9.

    Article  PubMed  Google Scholar 

  15. Oates TW, Dowell S, Robinson M, McMahan CA. Glycemic control and implant stabilization in type 2 diabetes mellitus. J Dent Res. 2009;88(4):367–71.

    Google Scholar 

  16. Eskow CC, Oates TW. Dental implant survival and complication rate over 2 years for individuals with poorly controlled Type 2 diabetes mellitus. Clin Implant Dent Relat Res. 2017;19(3):423–31.

    Article  PubMed  Google Scholar 

  17. Khandelwal N, Oates TW, Vargas A, Alexander PP, Schoolfield JD, Alex McMahan C. Conventional SLA and chemically modified SLA implants in patients with poorly controlled type 2 diabetes mellitus—a randomized controlled trial. Clin Oral Implants Res. 2013;24(1):13–9.

    Article  PubMed  Google Scholar 

  18. Oates TW Jr, Galloway P, Alexander P, Vargas Green A, Huynh-Ba G, Feine J, McMahan CA. The effects of elevated hemoglobin A(1c) in patients with type 2 diabetes mellitus on dental implants: survival and stability at one year. J Am Dent Assoc. 2014;145(12):1218–26.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Tawil G, Younan R, Azar P, Sleilati G. Conventional and advanced implant treatment in the type II diabetic patient: surgical protocol and long-term clinical results. Int J Oral Maxillofac Implants. 2008;23(4):744–52.

    PubMed  Google Scholar 

  20. Aguilar-Salvatierra A, Calvo-Guirado JL, González-Jaranay M, Moreu G, Delgado-Ruiz RA, Gómez-Moreno G. Peri-implant evaluation of immediately loaded implants placed in esthetic zone in patients with diabetes mellitus type 2: a two-year study. Clin Oral Implants Res. 2016;27(2):156–61.

    Article  PubMed  Google Scholar 

  21. Abduljabbar T, Al-sahaly F, Al-kathami M, Afzal S, Vohra F. Comparison of periodontal and peri-implant inflammatory parameters among patients with prediabetes, type 2 diabetes mellitus and non-diabetic controls. Acta Odontol Scand. 2017;75(5):319–24.

    Article  PubMed  Google Scholar 

  22. Alasqah MN, Alrabiah M, Al-Aali KA, Mokeem SA, Binmahfooz AM, ArRejaie AS, Abduljabbar T. Peri-implant soft tissue status and crestal bone levels around adjacent implants placed in patients with and without type-2 diabetes mellitus: 6 years follow-up results. Clin Implant Dent Relat Res. 2018;20(4):562–8.

    Article  PubMed  Google Scholar 

  23. Al Amri MD, Abduljabbar TS, Al-Johany SS, Al Rifaiy MQ, Alfarraj Aldosari AM, Al-Kheraif AA. Comparison of clinical and radiographic parameters around short (6 to 8 mm in length) and long (11 mm in length) dental implants placed in patients with and without type 2 diabetes mellitus: 3-year follow-up results. Clin Oral Implants Res. 2017;28(10):1182–7.

    Article  PubMed  Google Scholar 

  24. Al Amri MD, Abduljabbar TS. Comparison of clinical and radiographic status of platform-switched implants placed in patients with and without type 2 diabetes mellitus: a 24-month follow-up longitudinal study. Clin Oral Implants Res. 2017;28(2):226–30.

    Article  PubMed  Google Scholar 

  25. Al Amri MD, Kellesarian SV, Al-Kheraif AA, Malmstrom H, Javed F, Romanos GE. Effect of oral hygiene maintenance on HbA1c levels and peri-implant parameters around immediately-loaded dental implants placed in type-2 diabetic patients: 2 years follow-up. Clin Oral Implants Res. 2016;27(11):1439–43.

    Article  PubMed  Google Scholar 

  26. Cabrera-Domínguez J, Castellanos-Cosano L, Torres-Lagares D, Machuca-Portillo G. A prospective case-control clinical study of titanium-zirconium alloy implants with a hydrophilic surface in patients with Type 2 diabetes mellitus. Int J Oral Maxillofac Implants. 2017;32(5):1135–44.

    Article  PubMed  Google Scholar 

  27. Dŏgan ŞB, Kurtiş MB, Tüter G, Serdar M, Watanabe K, Karakış S. Evaluation of clinical parameters and levels of proinflammatory cytokines in the crevicular fluid around dental implants in patients with Type 2 diabetes mellitus. Int J Oral Maxillofac Implants. 2015;30(5):1119–27.

    Article  PubMed  Google Scholar 

  28. Erdogan Ö, Uçar Y, Tatlı U, Sert M, Benlidayı ME, Evlice B. A clinical prospective study on alveolar bone augmentation and dental implant success in patients with type 2 diabetes. Clin Oral Implants Res. 2015;26(11):1267–75.

    Article  PubMed  Google Scholar 

  29. Gómez-Moreno G, Aguilar-Salvatierra A, Rubio Roldán J, Guardia J, Gargallo J, Calvo-Guirado JL. Peri-implant evaluation in type 2 diabetes mellitus patients: a 3-year study. Clin Oral Implants Res. 2015;26(9):1031–5.

    Article  PubMed  Google Scholar 

  30. Raghav D, Alqahtani F, Albaker FJ, Bhagat TV, Kola Z. Intricate assessment and evaluation of long-term implant success as affected by clinicomicrobial and salivary diagnostics in Type II diabetic patients: a longitudinal study. J Contemp Dent Pract. 2017;18(5):405–9.

    Article  PubMed  Google Scholar 

  31. Tatarakis N, Kinney JS, Inglehart M, Braun TM, Shelburne C, Lang NP, Giannobile WV, Oh TJ. Clinical, microbiological, and salivary biomarker profiles of dental implant patients with type 2 diabetes. Clin Oral Implants Res. 2014;25(7):803–12.

    Article  PubMed  Google Scholar 

  32. Venza I, Visalli M, Cucinotta M, De Grazia G, Teti D, Venza M. Proinflammatory gene expression at chronic periodontitis and peri-implantitis sites in patients with or without type 2 diabetes. J Periodontol. 2010;81(1):99–108.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Periodontics, Department of Advanced Oral Sciences and Therapeutics, University of Maryland, Baltimore, MD, USA

    Thomas W. Oates, Alyssa Dierkes, Katherine Ni & Hanae Saito

Authors
  1. Thomas W. Oates
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alyssa Dierkes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Katherine Ni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hanae Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Thomas W. Oates .

Editor information

Editors and Affiliations

  1. Department of Periodontology, Nihon University School of Dentistry at Matsudo, Chiba, Japan

    Yorimasa Ogata

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Oates, T.W., Dierkes, A., Ni, K., Saito, H. (2020). Diabetes as a Systemic Factor for Peri-implantitis. In: Ogata, Y. (eds) Risk Factors for Peri-implant Diseases 　. Springer, Cham. https://doi.org/10.1007/978-3-030-39185-0_6

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-39185-0_6

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-39184-3

  • Online ISBN: 978-3-030-39185-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation